Axcella Health (AXLA) Stock Forecast, Price Target & Predictions
AXLA Stock Forecast
Axcella Health stock forecast is as follows: an average price target of $6.00 (represents a 31.00% upside from AXLA’s last price of $4.58) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
AXLA Price Target
AXLA Analyst Ratings
Buy
Axcella Health Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 03, 2022 | - | Leerink Partners | $6.00 | $2.03 | 195.57% | 31.00% |
10
Axcella Health Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $4.58 | $4.58 | $4.58 |
Upside/Downside | -100.00% | -100.00% | -100.00% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 16, 2022 | SVB Leerink | Buy | Market Perform | Downgrade |
Oct 03, 2022 | SVB Leerink | Buy | Buy | Hold |
Sep 29, 2022 | Roth Capital | Buy | Buy | Hold |
Aug 03, 2022 | SVB Leerink | Outperform | Outperform | Hold |
May 09, 2022 | Chardan Capital | Buy | Buy | Hold |
10
Axcella Health Financial Forecast
Axcella Health Revenue Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - |
# Analysts | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - |
Forecast
Axcella Health EBITDA Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | $-3.54M |
Avg Forecast | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - |
Forecast
Axcella Health Net Income Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - |
Net Income | - | - | - | - | - | $-3.41M |
Avg Forecast | $4.54M | $3.96M | $4.65M | $6.16M | $-3.68M | $3.51M |
High Forecast | $4.54M | $3.96M | $4.65M | $6.16M | $-3.68M | $3.51M |
Low Forecast | $4.54M | $3.96M | $4.65M | $6.16M | $-3.68M | $3.51M |
Surprise % | - | - | - | - | - | -0.97% |
Forecast
Axcella Health SG&A Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - |
SG&A | - | - | - | - | - | $2.32M |
Avg Forecast | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - |
Forecast
Axcella Health EPS Forecast
Quarter
Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - |
EPS | - | - | - | - | - | - |
Avg Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $-1.25 | $1.19 |
High Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $-1.25 | $1.19 |
Low Forecast | $1.54 | $1.34 | $1.58 | $2.09 | $-1.25 | $1.19 |
Surprise % | - | - | - | - | - | - |
Forecast
Axcella Health Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
AKTX | Akari Therapeutics | $1.24 | $12.00K | 967641.94% | - |
CTMX | CytomX Therapeutics | $0.87 | $5.73 | 558.62% | Buy |
TIL | Instil Bio | $24.76 | $78.25 | 216.03% | Hold |
NUVB | Nuvation Bio | $2.70 | $6.75 | 150.00% | Buy |
ASMB | Assembly Biosciences | $14.72 | $35.50 | 141.17% | Buy |
KZR | Kezar Life Sciences | $7.62 | $17.50 | 129.66% | Buy |
AXLA | Axcella Health | $4.58 | $6.00 | 31.00% | Buy |